144 related articles for article (PubMed ID: 25899618)
1. Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways.
Calzetta L; Cazzola M; Page CP; Rogliani P; Facciolo F; Matera MG
Pulm Pharmacol Ther; 2015 Jun; 32():15-23. PubMed ID: 25899618
[TBL] [Abstract][Full Text] [Related]
2. Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone.
Calzetta L; Page CP; Spina D; Cazzola M; Rogliani P; Facciolo F; Matera MG
J Pharmacol Exp Ther; 2013 Sep; 346(3):414-23. PubMed ID: 23766543
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.
Cazzola M; Calzetta L; Puxeddu E; Ora J; Facciolo F; Rogliani P; Matera MG
Respir Res; 2016 Jun; 17(1):70. PubMed ID: 27296533
[TBL] [Abstract][Full Text] [Related]
4. Interaction between corticosteroids and muscarinic antagonists in human airways.
Cazzola M; Calzetta L; Rogliani P; Puxeddu E; Facciolo F; Matera MG
Pulm Pharmacol Ther; 2016 Feb; 36():1-9. PubMed ID: 26656790
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi.
Cazzola M; Calzetta L; Page CP; Rogliani P; Facciolo F; Gavaldà A; Matera MG
Eur J Pharmacol; 2014 Dec; 745():135-43. PubMed ID: 25446566
[TBL] [Abstract][Full Text] [Related]
7. Novel relaxant effects of RPL554 on guinea pig tracheal smooth muscle contractility.
Venkatasamy R; Spina D
Br J Pharmacol; 2016 Aug; 173(15):2335-51. PubMed ID: 27174172
[TBL] [Abstract][Full Text] [Related]
8. Translational Study Searching for Synergy between Glycopyrronium and Indacaterol.
Cazzola M; Calzetta L; Segreti A; Facciolo F; Rogliani P; Matera MG
COPD; 2015 Apr; 12(2):175-81. PubMed ID: 25222881
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi.
Rogliani P; Calzetta L; Ora J; Lipsi R; Segreti A; Matera MG; Cazzola M
Eur J Pharmacol; 2015 Aug; 761():383-90. PubMed ID: 25952728
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways.
Calzetta L; Rogliani P; Page C; Rinaldi B; Cazzola M; Matera MG
Pulm Pharmacol Ther; 2019 Jun; 56():39-50. PubMed ID: 30876907
[TBL] [Abstract][Full Text] [Related]
11. Ensifentrine (RPL554): an inhaled 'bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease.
Cazzola M; Page C; Calzetta L; Matera MG
Pharm Pat Anal; 2018 Nov; 7(6):249-257. PubMed ID: 30657422
[TBL] [Abstract][Full Text] [Related]
12. The dual phosphodiesterase 3/4 inhibitor RPL554 stimulates rare class III and IV CFTR mutants.
Turner MJ; Luo Y; Thomas DY; Hanrahan JW
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L908-L920. PubMed ID: 32159371
[TBL] [Abstract][Full Text] [Related]
13. The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one].
Boswell-Smith V; Spina D; Oxford AW; Comer MB; Seeds EA; Page CP
J Pharmacol Exp Ther; 2006 Aug; 318(2):840-8. PubMed ID: 16682455
[TBL] [Abstract][Full Text] [Related]
14. The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia.
Turner MJ; Matthes E; Billet A; Ferguson AJ; Thomas DY; Randell SH; Ostrowski LE; Abbott-Banner K; Hanrahan JW
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(1):L59-70. PubMed ID: 26545902
[TBL] [Abstract][Full Text] [Related]
15. Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo.
Rogliani P; Matera MG; Facciolo F; Page C; Cazzola M; Calzetta L
Br J Pharmacol; 2020 Mar; 177(5):1150-1163. PubMed ID: 31660611
[TBL] [Abstract][Full Text] [Related]
16. Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways.
Rogliani P; Ritondo BL; Facciolo F; Matera MG; Nikolaev I; Calzetta L
Pharmacol Res; 2021 Oct; 172():105801. PubMed ID: 34363950
[TBL] [Abstract][Full Text] [Related]
17. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
Torphy TJ; Undem BJ; Cieslinski LB; Luttmann MA; Reeves ML; Hay DW
J Pharmacol Exp Ther; 1993 Jun; 265(3):1213-23. PubMed ID: 8389856
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi.
Calzetta L; Rogliani P; Mattei M; Alfonsi P; Cito G; Pistocchini E; Cazzola M; Matera MG
COPD; 2017 Oct; 14(5):526-532. PubMed ID: 28745522
[TBL] [Abstract][Full Text] [Related]
19. Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD.
Cazzola M; Calzetta L; Rogliani P; Matera MG
Expert Opin Investig Drugs; 2019 Oct; 28(10):827-833. PubMed ID: 31474120
[No Abstract] [Full Text] [Related]
20. Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi.
Calzetta L; Rogliani P; Facciolo F; Rendina E; Cazzola M; Matera MG
Eur J Pharmacol; 2017 Oct; 812():147-154. PubMed ID: 28716723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
